Oral herpes drug developer Squarex Pharmaceuticals files for $15M IPO
anotherperfectday Squarex Pharmaceuticals (SQRX) has filed to raise $15M through an initial public offering to help fund development of its product to prevent cold sore outbreaks. The biotech company didn’t…